Trials / Recruiting
RecruitingNCT06271707
Stellate Ganglion Block
Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.5% bupivacaine | an ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine |
| OTHER | Saline | an ultrasound guided left stellate ganglion block with 5 mL of saline |
Timeline
- Start date
- 2025-05-19
- Primary completion
- 2027-04-15
- Completion
- 2027-07-15
- First posted
- 2024-02-22
- Last updated
- 2025-09-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06271707. Inclusion in this directory is not an endorsement.